These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 3005181

  • 1. Pharmacodynamics and population pharmacokinetics of enalapril and lisinopril.
    Ajayi AA, Campbell BC, Kelman AW, Howie C, Meredith PA, Reid JL.
    Int J Clin Pharmacol Res; 1985; 5(6):419-27. PubMed ID: 3005181
    [Abstract] [Full Text] [Related]

  • 2. Pharmacokinetics of enalapril and lisinopril in subjects with normal and impaired hepatic function.
    Hayes PC, Plevris JN, Bouchier IA.
    J Hum Hypertens; 1989 Jun; 3 Suppl 1():153-8. PubMed ID: 2550638
    [Abstract] [Full Text] [Related]

  • 3. Comparative pharmacokinetics and pharmacodynamics of lisinopril and enalapril, alone and in combination with propranolol.
    Bendtsen F, Henriksen JH.
    J Hum Hypertens; 1989 Jun; 3 Suppl 1():139-45. PubMed ID: 2550636
    [Abstract] [Full Text] [Related]

  • 4. A clinical pharmacological study of nifedipine and lisinopril alone and in combination.
    Lees KR, Meredith PA, Reid JL.
    J Cardiovasc Pharmacol; 1987 Jun; 10 Suppl 10():S105-7. PubMed ID: 2455105
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of angiotensin converting enzyme from sheep tissues by captopril, lisinopril and enalapril.
    Udupa EG, Rao NM.
    Indian J Biochem Biophys; 1997 Dec; 34(6):524-8. PubMed ID: 9594434
    [Abstract] [Full Text] [Related]

  • 6. Pharmacokinetic and pharmacodynamic comparative study of zofenopril and enalapril in healthy volunteers.
    Marzo A, Dal Bo L, Mazzucchelli P, Monti NC, Crivelli F, Ismaili S, Giusti A, Uhr MR.
    Arzneimittelforschung; 2002 Dec; 52(4):233-42. PubMed ID: 12040965
    [Abstract] [Full Text] [Related]

  • 7. Measurements of serum ACE activity in vitro after administration of enalapril in man cannot reflect inhibition of the enzyme in vivo.
    Weisser K, Schloos J.
    Methods Find Exp Clin Pharmacol; 1993 Dec; 15(6):413-8. PubMed ID: 8231461
    [Abstract] [Full Text] [Related]

  • 8. The clinical pharmacology of lisinopril.
    Case DE.
    J Hum Hypertens; 1989 Jun; 3 Suppl 1():127-31. PubMed ID: 2550635
    [Abstract] [Full Text] [Related]

  • 9. Relationship of antihypertensive effect of enalapril to serum MK-422 levels and angiotensin converting enzyme inhibition.
    Johnston CI, Jackson B, McGrath B, Matthews G, Arnolda L.
    J Hypertens Suppl; 1983 Oct; 1(1):71-5. PubMed ID: 6100611
    [Abstract] [Full Text] [Related]

  • 10. Radioimmunoassay for the quantitation of lisinopril and enalaprilat.
    Worland PJ, Jarrott B.
    J Pharm Sci; 1986 May; 75(5):512-6. PubMed ID: 3016233
    [Abstract] [Full Text] [Related]

  • 11. Comparative pharmacokinetics of enalapril and lisinopril, alone and with hydralazine.
    McLean AJ, Drummer OH, Smith HJ, Froomes P, McNeil JJ.
    J Hum Hypertens; 1989 Jun; 3 Suppl 1():147-51. PubMed ID: 2550637
    [Abstract] [Full Text] [Related]

  • 12. A comparison of lisinopril with enalapril by monitoring plasma angiotensin II levels in humans.
    Kawamura M, Imanishi M, Matsushima Y, Akabane S, Kuramochi M, Ito K, Omae T.
    Jpn J Pharmacol; 1990 Oct; 54(2):143-9. PubMed ID: 1963909
    [Abstract] [Full Text] [Related]

  • 13. Correlation between ACE activity and mean blood pressure in Iranian normotensive subjects after oral administration of a single dose of enalapril.
    Ziai SA, Seyedhosseini D, Taiebi L, Salekmoghadam E, Mahmoudian M.
    Acta Physiol Hung; 2000 Oct; 87(2):153-9. PubMed ID: 11205963
    [Abstract] [Full Text] [Related]

  • 14. Hemodynamic, hormonal, and pharmacokinetic aspects of treatment with lisinopril in congestive heart failure.
    Dickstein K.
    J Cardiovasc Pharmacol; 1987 Oct; 9 Suppl 3():S73-81. PubMed ID: 2442558
    [Abstract] [Full Text] [Related]

  • 15. Differential renal handling of angiotensin-converting enzyme inhibitors enalaprilat and lisinopril in rats.
    Lin JH, Chen IW, Ulm EH, Duggan DE.
    Drug Metab Dispos; 1988 Oct; 16(3):392-6. PubMed ID: 2900730
    [Abstract] [Full Text] [Related]

  • 16. Effect of dietary sodium on angiotensin-converting enzyme (ACE) inhibition and the acute hypotensive effect of enalapril (MK-421) in essential hypertension.
    Jackson B, Cubela R, Johnston CI.
    J Hypertens; 1984 Aug; 2(4):371-7. PubMed ID: 6099390
    [Abstract] [Full Text] [Related]

  • 17. Angiotensin converting enzyme inhibition in plasma and tissues.
    Johnston CI, Cubela R, Sakaguchi K, Jackson B.
    Clin Exp Hypertens A; 1987 Aug; 9(2-3):307-21. PubMed ID: 3038391
    [Abstract] [Full Text] [Related]

  • 18. Pharmacokinetics and pharmacodynamics profiles of enalapril maleate in healthy volunteers following determination of enalapril and enalaprilat by two specific enzyme immunoassays.
    Arafat T, Awad R, Hamad M, Azzam R, Al-Nasan A, Jehanli A, Matalka K.
    J Clin Pharm Ther; 2005 Aug; 30(4):319-28. PubMed ID: 15985045
    [Abstract] [Full Text] [Related]

  • 19. Age and the pharmacokinetics and pharmacodynamics of chronic enalapril treatment.
    Lees KR, Reid JL.
    Clin Pharmacol Ther; 1987 Jun; 41(6):597-602. PubMed ID: 3034468
    [Abstract] [Full Text] [Related]

  • 20. Enalapril and lisinopril in renovascular hypertension--antihypertensive and hormonal effects of two new angiotensin-converting-enzyme (ACE) inhibitors. A preliminary report.
    Karlberg BE, Fyhrquist F, Grönhagen-Riska C, Tikkanen I, Ohman KP.
    Scand J Urol Nephrol Suppl; 1984 Jun; 79():103-6. PubMed ID: 6089307
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.